Superpower has begun piloting its preventive health platform with Sequoia's 800-person workforce, with plans to extend access to Sequoia's client organizations, which the company reports number more than 2,500 employers covering over 600,000 people. The platform converts a single blood draw into longitudinal monitoring — more than 150 biomarkers combined with health records and wearable data, a personalized action plan, clinical support and scheduled retesting. The model places dense biomarker surveillance inside employer benefits infrastructure rather than individual consumer purchasing.
Key Points
- Pilot covers 800+ employees, with 2,500 client companies next
- 150+ biomarkers merged with health records and wearable data
- Retesting and proactive outreach track change over time
Longevity Analysis
Repeat measurement is what separates useful biomarker data from a snapshot. A single panel describes a moment; serial panels paired with wearable data reveal the direction a person's metabolic, hormonal and inflammatory markers are moving, which is where intervention becomes possible before disease is named. Delivering this through employers addresses the harder problem — sustained participation — by removing cost and logistics as barriers, though the value ultimately depends on whether flagged signals translate into interpreted action rather than accumulating unread results.
Original published by Longevity.Technology.